March 25, 2019
A shareholder in Osiris Therapeutics Inc. has filed a proposed class action in Maryland federal court challenging the terms of a planned $660 million merger with competitor Smith & Nephew PLC, saying the sports medicine and orthopedics firm is being undervalued in the deal.